![Andrew John Matthew Clark](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Andrew John Matthew Clark
Presidente presso vasopharm GmbH
Patrimonio netto: 235 507 $ in data 31/05/2024
Profilo
Andrew John Matthew Clark was the founder of Reabourne Ltd., which was founded in 1995 where he held the title of Portfolio Manager from 1995 to 2003.
He is currently the Chairman-Supervisory Board at vasopharm GmbH.
Dr. Clark's former positions include Director at Liminal BioSciences, Inc., Senior Independent Non-Executive Director at Lifeline Scientific, Inc., and Director at Hologic Ltd.
Dr. Clark received a doctorate degree from the University of St. Andrews.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
01/05/2023 | 3 066 502 ( 1.08% ) | 235 507 $ | 31/05/2024 |
Posizioni attive di Andrew John Matthew Clark
Società | Posizione | Inizio |
---|---|---|
vasopharm GmbH
![]() vasopharm GmbH Pharmaceuticals: MajorHealth Technology vasopharm GmbH operates as a pharmaceutical company. It discovers and develops novel therapeutics for the treatment of cerebro and cardiovascular diseases and their consequences. The firm focuses on therapeutics influencing the bioavailability of nitric oxide. The company was founded by Harald Schmidt and Ulrich Walter in July 1998 and is headquartered in Wuerzburg, Germany. | Presidente | - |
Precedenti posizioni note di Andrew John Matthew Clark
Società | Posizione | Fine |
---|---|---|
Reabourne Ltd. | Fondatore | 01/01/2003 |
LIMINAL BIOSCIENCES INC. | Direttore/Membro del Consiglio | - |
LIFELINE SCIENTIFIC, INC | Direttore/Membro del Consiglio | - |
Hologic Ltd.
![]() Hologic Ltd. Medical SpecialtiesHealth Technology Hologic Ltd. manufactures life sciences products and services with two divisions, Molecular Diagnostics and Research Products & Services. The firm has laboratories, manufacturing and operations in the USA, UK and France. It provides test kits, reagents and services to two synergistic markets. It focuses on these niche opportunities with products, patents, expertise and acquisitions. The company was founded in 1992 and is headquartered in Wythenshawe, the United Kingdom. | Direttore/Membro del Consiglio | - |
Formazione di Andrew John Matthew Clark
University of St. Andrews | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
LIMINAL BIOSCIENCES INC. | Health Technology |
Aziende private | 4 |
---|---|
Reabourne Ltd. | |
Hologic Ltd.
![]() Hologic Ltd. Medical SpecialtiesHealth Technology Hologic Ltd. manufactures life sciences products and services with two divisions, Molecular Diagnostics and Research Products & Services. The firm has laboratories, manufacturing and operations in the USA, UK and France. It provides test kits, reagents and services to two synergistic markets. It focuses on these niche opportunities with products, patents, expertise and acquisitions. The company was founded in 1992 and is headquartered in Wythenshawe, the United Kingdom. | Health Technology |
vasopharm GmbH
![]() vasopharm GmbH Pharmaceuticals: MajorHealth Technology vasopharm GmbH operates as a pharmaceutical company. It discovers and develops novel therapeutics for the treatment of cerebro and cardiovascular diseases and their consequences. The firm focuses on therapeutics influencing the bioavailability of nitric oxide. The company was founded by Harald Schmidt and Ulrich Walter in July 1998 and is headquartered in Wuerzburg, Germany. | Health Technology |
Lifeline Scientific, Inc.
![]() Lifeline Scientific, Inc. Medical SpecialtiesHealth Technology Lifeline Scientific, Inc. engages in the development and marketing of advanced medical products and services. It focuses on tissue testing technologies. It also intends to provide more and better quality organs, tissues and cells, in support of transplant professionals worldwide, and the life-saving services. The company was founded by David Kravitz on October 1, 1998 and is headquartered in Itasca, IL. | Health Technology |
- Borsa valori
- Insiders
- Andrew John Matthew Clark